Jay Anders, MD, CMO of Medicomp Systems writes for Medical Economics on AHIP’s recent press release and their stance on the new CMS final rule regarding Risk Adjustment Data Validation for Medicare Advantage (MA) plans. Read the full article here.
Jay Anders, MD, CMO of Medicomp Systems writes for Medical Economics on AHIP’s recent press release and their stance on the new CMS final rule regarding Risk Adjustment Data Validation for Medicare Advantage (MA) plans. Read the full article here.
To mark the 20th anniversary of value-based care, health care innovation and VBC leaders, including David Lareau, share thoughts on how the industry has evolved: “Value-based care has the right …Continue
David Lareau writes that the real challenge facing health data platform companies and health system data teams is what to do with all of the clinical data. The next phase …Continue
Dr. Jay Anders, CMO at Medicomp, cautions that clinicians are concerned about AI tools’ hallucinations and inconsistent outputs, so more governance and stronger guardrails are needed to get their buy-in.